Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor
- Eur J Med Chem. 2016 Nov 29:124:773-781. doi: 10.1016/j.ejmech.2016.09.014.
- 1. Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy.
- 2. Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131, Napoli, Italy.
- 3. Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium.
- 4. Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano, SA, Italy. Electronic address: [email protected].
- 5. Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131, Napoli, Italy. Electronic address: [email protected].
We report the synthesis and Antiviral activity of a new family of non-nucleoside antivirals, derived from the indole nucleus. Modifications of this template through Mannich and Friedel-Crafts reactions, coupled with nucleophilic displacement and reductive aminations led to 23 final derivatives, which were pharmacologically tested. Tryptamine derivative 17a was found to have a selective inhibitory activity against human varicella zoster virus (VZV) replication in vitro, being inactive against a variety of Other DNA and RNA viruses. A structure-activity relationship (SAR) study showed that the presence of a biphenyl ethyl moiety and the acetylation at the amino group of tryptamine are a prerequisite for anti-VZV activity. The novel compound shows the same activity against thymidine kinase (TK)-competent (TK+) and TK-deficient (TK-) VZV strains, pointing to a novel mechanism of Antiviral action.